These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12913727)

  • 1. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
    Cooperberg M; Lubeck DP; Penson D; Mehta SS; Carroll PR; Kane CJ
    J Urol; 2003 Sep; 170(3):905-8. PubMed ID: 12913727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE.
    Knight SJ; Latini DM; Hart SL; Sadetsky N; Kane CJ; DuChane J; Carroll PR;
    Cancer; 2007 May; 109(9):1769-76. PubMed ID: 17380491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
    Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
    Ryan CJ; Elkin EP; Small EJ; Duchane J; Carroll P
    Urol Oncol; 2006; 24(5):396-402. PubMed ID: 16962488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
    Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
    J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
    Meng MV; Elkin EP; Latini DM; Duchane J; Carroll PR
    J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionate presentation of high risk prostate cancer in a safety net health system.
    Porten SP; Richardson DA; Odisho AY; McAninch JW; Carroll PR; Cooperberg MR
    J Urol; 2010 Nov; 184(5):1931-6. PubMed ID: 20846693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
    Kane CJ; Bassett WW; Sadetsky N; Silva S; Wallace K; Pasta DJ; Cooperberg MR; Chan JM; Carroll PR
    J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
    Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
    J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
    Macdonald OK; D'Amico AV; Sadetsky N; Shrieve DC; Carroll PR
    Urology; 2007 Jul; 70(1):106-10. PubMed ID: 17656218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System.
    Rabeneck L; Souchek J; El-Serag HB
    Am J Gastroenterol; 2003 May; 98(5):1186-92. PubMed ID: 12809847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual use of Veterans Affairs services and use of recommended ambulatory care.
    Ross JS; Keyhani S; Keenan PS; Bernheim SM; Penrod JD; Boockvar KS; Krumholz HM; Siu AL
    Med Care; 2008 Mar; 46(3):309-16. PubMed ID: 18388846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.